liu.seSearch for publications in DiVA
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
A population-based study of cervical carcinoma and HPV infection in Latvia.
Oncology Center of Latvia, Riga, Latvia / Department of Gynecologic Oncology, Radiumhemmet, Karolinska Hospital, Stockholm, Sweden / Department of Medical Microbiology, MAS University Hospital, Malmö, Sweden.
Linköpings universitet, Institutionen för teknik och naturvetenskap, Fysik och elektroteknik. Linköpings universitet, Tekniska högskolan. Department of Medical Microbiology, MAS University Hospital, Malmö, Sweden.
Merck Research Laboratories, West Point, PA 19486, USA.
Merck Research Laboratories, West Point, PA 19486, USA.
Vise andre og tillknytning
2004 (engelsk)Inngår i: Gynecologic Oncology, ISSN 0090-8258, E-ISSN 1095-6859, Vol. 93, nr 2, s. 484-492Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

OBJECTIVES: We wished to quantify the population-based importance of cervical carcinoma risk factors in Latvia.

METHODS: Totally, 223 of 224 eligible cases of incident invasive cervical carcinoma were enrolled during July 1998-February 2001 in Latvia. An age-matched sample of 300 healthy control women was selected from the Latvian population registry and 239 of these women (79%) were enrolled. A demographic and life-style questionnaire was completed, cervical brush samples were analyzed for human papillomavirus (HPV) DNA by PCR and serum samples for HPV antibodies.

RESULTS: Risk factors for cervical cancer in multivariate analysis were HPV type 16 or 18 DNA positivity (OR = 32.4; CI 95% 16.5-63.6) and living in the capital (OR = 2.4; CI 95% 1.2-4.7). Oral contraceptive use was not a risk factor (OR = 0.4; CI 95% 0.2-1.1). A strong protective effect was found for having had more than three Pap smears in the last 5 years (OR = 0.07 CI 95% 0.03-0.19).

CONCLUSIONS: Inadequate population coverage of Pap smears, in spite of excessive smear usage, caused 28.4% of cervical cancers in age groups eligible for screening. HPV type 16 infection was the most important risk factor for cervical cancer in Latvia, with a population-attributable risk percent for all ages of 58.5%.

sted, utgiver, år, opplag, sider
Academic Press, 2004. Vol. 93, nr 2, s. 484-492
Emneord [en]
Cervical cancer, Epidemiology, HPV infection, Screening
HSV kategori
Identifikatorer
URN: urn:nbn:se:liu:diva-113935DOI: 10.1016/j.ygyno.2004.01.044ISI: 000221120500035PubMedID: 15099967Scopus ID: 2-s2.0-1942508837OAI: oai:DiVA.org:liu-113935DiVA, id: diva2:785727
Tilgjengelig fra: 2015-02-03 Laget: 2015-02-03 Sist oppdatert: 2017-04-20bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Wang, XiaodongÅvall-Lundqvist, Elisabeth

Søk i DiVA

Av forfatter/redaktør
Wang, XiaodongÅvall-Lundqvist, Elisabeth
Av organisasjonen
I samme tidsskrift
Gynecologic Oncology

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 157 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf